Cheng Ho Ming, et al.
Atherosclerosis, 2017
Abstract
Background and aims
Epidemiological evidence suggests an association between consumption of tomato products or lycopene and lower risk for cardiovascular diseases (CVD). Our aim was to evaluate the state of the evidence from intervention trials on the effect of consuming tomato products and lycopene on markers of cardiovascular (CV) function. We undertook a systematic review and meta-analysis on the effect of supplementing tomato and lycopene on CV risk factors.
Methods
Three databases including Medline, Web of science, and Scopus were searched from inception to August 2016. Inclusion criteria were: intervention trials reporting effects of tomato products and lycopene supplementation on CV risk factors among adult subjects >18 years of age. The outcomes of interest included blood lipids (total-, HDL-, LDL-cholesterol, triglycerides, oxidised-LDL), endothelial function (flow-mediated dilation (FMD), pulse wave velocity (PWV)) and blood pressure (BP) inflammatory factors (CRP, IL-6) and adhesion molecules (ICAM-1). Random-effects models were used to determine the pooled effect sizes.
Results
Out of 1189 publications identified, 21 fulfilled inclusion criteria and were meta-analysed. Overall, interventions supplementing tomato were associated with significant reductions in LDL-cholesterol (-0.22 mmol/L; p = 0.006), IL-6 (standardised mean difference -0.25; p = 0.03), and improvements in FMD (2.53%; p = 0.01); while lycopene supplementation reduced systolic-BP (-5.66 mmHg; p = 0.002). No other outcome was significantly affected by these interventions.
Conclusions
The available evidence on the effects of tomato products and lycopene supplementation on CV risk factors supports the view that increasing the intake of these has positive effects on blood lipids, blood pressure and endothelial function. These results support the development of promising individualised nutritional strategies involving tomatoes to tackle CVD.
Copyright © 2017 Elsevier B.V. All rights reserved.
Keywords
Blood lipids; Blood pressure; Cardiovascular risk factors; Endothelial function; Inflammatory factors; Intervention; Lycopene; Meta-analysis; Systematic review; Tomato
| PMID: | 28129549 |
|---|---|
| Category: | Heart Health |
Articles similar to "Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis."
- The impact of Lycopersicon Esculentum on Heart Health: Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. (Cardiovascular disease (CVD) is a major contributor to morbidity and mortality in the United States and worldwide...)
- The impact of Lycopene on Heart Health: Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. (The management of overweight subjects by interventions aimed at reducing inflammation is highly desirable...)
- The significance of Lycopene for Heart Health: Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial. (AIMS: The mechanisms by which a 'Mediterranean diet' reduces cardiovascular disease (CVD) burden remain poorly understood... Lycopene supplementation improves endothelial function in CVD patients on optimal secondary prevention, but not in HVs. TRIAL REGISTRATION: ClinicalTrials.gov NCT01100385.)